Elsevier Publishes Five New Books on Toxicology

New book, Biomarkers in Toxicology by Dr. Ramesh Gupta, highlighted at SOT's ToxExpo in Phoenix this week

Waltham, MA, March 24, 2014

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of five new books on toxicology, including Biomarkers in Toxicology by Ramesh C. Gupta, DVM, MVSc, PhD, DABT, FACT, FACN, FATS. Advancing clinical and translational toxicology and the application of biomarkers is a major theme at the Society of Toxicology Annual Meeting and ToxExpo in Phoenix this week. These new books will be on display at Elsevier’s ToxExpo booth #825.

Biomarkers in Toxicology is a timely and comprehensive reference dedicated to aspects of biomarkers that relate to chemical exposure and their effects on biological systems, bringing together a unique and focused evaluation of the latest research and technologies in this area. It includes both vertebrate and non-vertebrate species models for toxicological testing and development of biomarkers. This reference volume contains chapters written by leading subject-matter experts on important topics and applications of biomarkers in molecular toxicology, nanotoxicology, biomonitoring, drug efficacy evaluation and more.

Dr. Gupta is editor of five toxicology books with Elsevier and served as Guest Editor for Elsevier journal Toxicology and Applied Pharmacology. With over 350 publications to his credit, he has extensive research experience in biomarkers of pesticides, metals, mycotoxins, nutraceuticals and neurodegenerative diseases. Dr. Gupta is currently Professor and Head of the Toxicology Department, Breathitt Veterinary Center, Murray State University, Hopkinsville, Ky.

The full list of new toxicology books, published under the Academic Press imprint, includes:

The books are available on the Elsevier Store and on ScienceDirect, Elsevier’s full-text scientific database offering journal articles and book chapters from more than nearly 2,200 peer-reviewed journals, almost 900 serials and 25,000 book titles.

Notes for Editors
Review copies of the books are available to credentialed journalists upon request. Contact Michelle McMahon at m.mcmahon.1@elsevier.com or +1 781 663 2268.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 33,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Michelle McMahon
Publicity Manager, Science & Technology Books
+1 781 663 2268